# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-091804
Filing Date
2024-08-06
Accepted
2024-08-06 16:10:29
Documents
75
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | dvax-20240630.htm iXBRL | 10-Q | 2753681
2 | EX-10.1 | dvax-ex10_1.htm | EX-10.1 | 301585
3 | EX-10.2 | dvax-ex10_2.htm | EX-10.2 | 47666
4 | EX-31.1 | dvax-ex31_1.htm | EX-31.1 | 14115
5 | EX-31.2 | dvax-ex31_2.htm | EX-31.2 | 13831
6 | EX-32.1 | dvax-ex32_1.htm | EX-32.1 | 8593
7 | EX-32.2 | dvax-ex32_2.htm | EX-32.2 | 8747
| Complete submission text file | 0000950170-24-091804.txt |  | 11466781

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | dvax-20240630.xsd | EX-101.SCH | 1589510
78 | EXTRACTED XBRL INSTANCE DOCUMENT | dvax-20240630_htm.xml | XML | 2125550

Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 241179309
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)